The goals of the Third National Hepatitis B Strategy are to:
- Make significant progress towards eliminating hepatitis B as a public health threat
- Reduce mortality and morbidity related to hepatitis B
- Eliminate the negative impact of stigma, discrimination, and legal and human rights issues on people’s health
- Minimise the personal and social impact of hepatitis B.
Please find the link to the full Hepatitis B Strategy document here.
Targets – Hepatitis B
The seven targets in the National Hepatitis Strategy provide a specific focus for the efforts made towards achieving the goals of this Strategy:-
1.1 Achieve and maintain hepatitis B childhood vaccination coverage of 95% at 12 and 24 months
1.2 Reduce the number of newly acquired hepatitis B infections across all age groups by 50%, with a focus on priority populations
1.3 Increase the proportion of people living with chronic hepatitis B who are diagnosed to 80%
1.4 Increase the total proportion of people living with chronic hepatitis B receiving care to 50%
1.5 For people living with chronic hepatitis B, increase the proportion of people receiving antiviral treatment to 20%
1.6 Reduce hepatitis B attributable mortality by 30%
1.7 Minimise the reported experience of stigma among people living with hepatitis B, and the expression of stigma, in respect to hepatitis B status.
Indicators to monitor progress towards achieving the goals' targets are presented in the interactive dashboard below. Please note that data for Indicators 3c and 7a are currently in development and will be presented on the dashboard as they become available.
These tables are interactive, allowing you to filter and present the data in detail.
Choose the category/populations of interest using the drop down menus.
Hover the mouse over the charts to reveal further details.
These graphics are best viewed in full screen by clicking the box icon to the bottom-right of the tables.
You can export a PDF version of the selected view by selecting the download icon under the dashboard.
Click here for the executive summary: Tracking the Progress 2022: National Hepatitis B Strategy